Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Non-Current Assets (2017 - 2024)

Solid Biosciences' Non-Current Assets history spans 8 years, with the latest figure at $32.3 million for Q3 2024.

  • For Q3 2024, Non-Current Assets fell 11.13% year-over-year to $32.3 million; the TTM value through Sep 2024 reached $32.3 million, down 78.9%, while the annual FY2023 figure was $35.2 million, 13.32% down from the prior year.
  • Non-Current Assets for Q3 2024 was $32.3 million at Solid Biosciences, down from $33.4 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $40.6 million in Q4 2022 and bottomed at $8.9 million in Q1 2022.
  • The 5-year median for Non-Current Assets is $32.3 million (2024), against an average of $24.8 million.
  • The largest annual shift saw Non-Current Assets tumbled 31.59% in 2021 before it soared 335.67% in 2023.
  • A 5-year view of Non-Current Assets shows it stood at $12.3 million in 2020, then decreased by 20.38% to $9.8 million in 2021, then skyrocketed by 315.79% to $40.6 million in 2022, then dropped by 13.32% to $35.2 million in 2023, then dropped by 8.16% to $32.3 million in 2024.
  • Per Business Quant, the three most recent readings for SLDB's Non-Current Assets are $32.3 million (Q3 2024), $33.4 million (Q2 2024), and $34.5 million (Q1 2024).